Arisz Acquisition, a blank check company formed by MSQ Ventures targeting healthcare, raised $60 million by offering 6 million units at $10. Each unit consists of one share of common stock, one right to receive one-twentieth of a share upon the completion of an initial business combination, and one warrant to purchase three-quarters of a share, exercisable at $11.50.
The company is led by CEO and Chair Echo Hindle-Yang, the founder and CEO of MSQ Ventures, an advisory firm focused on integration for emerging life sciences companies. The company plans to leverage management's experience and target the global healthcare industry.
Arisz Acquisition plans to list on the Nasdaq under the symbol ARIZU. Chardan Capital Markets acted as sole bookrunner on the deal.
